Prednisolone Sodium Phosphate

Drug Class: Topical Anti-inflammatory, Systemic
Dosage Form: Injection
Strength: 10mg/ml, 25mg/ml
Indications/Special comments: Suppression of inflammatory and allergic disorders; inflammatory bowel disease, asthma, and rheumatic disease, for the treatment of adrenocortical insufficiency and as immune suppression
Dosage Administration: Adult Antiinflammatory Dosing: IV or IM: 4 to 60 mg/day. For intraarticular, intralesional or soft tissue administration: Large joints: 10 to 20 mg; Small joints: 4 to 5 mg; Bursae: 10 to 15 mg; Tendon sheaths: 2 to 5 mg; Soft tissue infiltration: 10 to 30 mg; Ganglia: 5 to 10 mg. Injectable suspension (tebutate) for intraarticular, intralesional or soft tissue administration: Large joints: 20 to 30 mg (doses > 40 mg not recommended); Small joints: 8 to 10 mg; Bursae: 20 to 30 mg; Tendon sheaths: 4 to 10 mg; Ganglia: 10 to 20 mg. Injectable suspension (acetate) for intraarticular, intralesional or soft tissue administration: 4 to 100 mg; Bursae: 10 to 15 mg; Tendon sheaths: 2 to 5 mg; Soft tissue infiltration: 10 to 30 mg.